AS PER THE FILE ATTACHED
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Continental Chemicals Ltd (BSE: 506935) held a board meeting on 13 November 2025 (4:00 PM to 4:30 PM) at its Noida registered office, where the directors approved the unaudited financial results along with the limited review report for the quarter and half year ended 30 September 2025. Total assets stood at approximately ₹634 lakhs as on 30 September 2025, marginally up from ₹604 lakhs as on 31 March 2025. Cash and cash equivalents improved to ₹10.06 lakhs from ₹6.77 lakhs, and net cash from operating activities swung to a positive ₹4.15 lakhs in H1 FY26, compared to a negative ₹10.25 lakhs in the previous full year. The board also took note of quarterly SEBI LODR compliances for Q2 FY26. No dividend, fundraising, or other major corporate action was announced.
This is a routine quarterly results and compliance filing with no major corporate actions. The improvement in cash position and a return to positive operating cash flow are mildly positive signals, but given the very small scale of operations (total assets under ₹7 crores), the stock is unlikely to see meaningful price action on this news.